<DOC>
	<DOCNO>NCT02780336</DOCNO>
	<brief_summary>The aim study develop new rating scale help diagnose measure severity blepharospasm . This condition involve lot blink spasm eye closure people ca n't control . This study also test video software see help diagnose people tell severity disease use video record exam . There additional plan create educational video teach others proper use scale video software .</brief_summary>
	<brief_title>Blepharospasm Tools</brief_title>
	<detailed_description>Blepharospasm chronic disorder characterize many contraction muscle around eye nearby facial muscle , lead involuntary eye closure . This study involve comprehensive evaluation patient blepharospasm , eye face disorder , people without neurologic eye face disorder . It address abnormal movement muscle around eye , pain muscle , psychological accompaniment , impact regular daily life . The evaluation participant do single visit , may take 1.5 hour complete . Each participant study ask follow : - Provide copy medical record provide medical history relate diagnosis blepharospasm . - Have examination neurologist ophthalmologist reveal feature extent dystonia eye face disorder . The examination video record review later different expert . - Complete questionnaire quality life psychiatric well The doctor also complete various scale questionnaire base participant 's study visit .</detailed_description>
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Blepharospasm</mesh_term>
	<criteria>BLEPHAROSPASM ( BL ) GROUP Diagnosed Focal , Multifocal Segmental Isolated Dystonia Onset Adulthood , must include blepharospasm . Sufficiently symptomatic recruitment ensure ( eye ) problem evident evaluator . Has ability provide inform consent follow study direction . Evidence secondary cause dystonia define blepharospasm cause drug exposure , parkinsonism , stroke . Suspected psychogenic movement eye disorder . Has surgical intervention blepharospasm eye problem may confound interpretation , orbital myectomy , blepharoplasty , deep brain stimulation surgery . Is treated dopamine receptor antagonist . Received BTX injection/botulinum toxin le 10 week prior study visit . Taking concomitant medication n't stable dos least 1 month prior study enrollment . Has significant medical neurological condition preclude complete video protocol questionnaire . Has significant physical condition would confound diagnosis evaluation . DISEASE CONTROL GROUP : Diagnosed facial eye disorder confuse blepharospasm , include , limited , hemifacial spasm , facial tic , psychogenic facial disorder , apraxia , ptosis due weakness . It permissible problem part Bell 's palsy , myasthenia gravis , Progressive Supranuclear Palsy ( PSP ) . Has significant dystonia body part . Sufficiently symptomatic recruitment ensure ( eye ) problem evident evaluator . Has ability provide inform consent follow study direction . Significant dystonia . Evidence secondary blepharospasm define blepharospasm cause drug exposure stroke . Received BTX injection/botulinum toxin le 10 week prior study visit . Taking concomitant medication n't stable dos least 1 month prior study enrollment . Unable provide inform consent follow study direction . Has significant medical neurological condition preclude complete video protocol questionnaire . Has significant physical condition would confound diagnosis evaluation . NORMAL CONTROL GROUP : Has facial eye problem neurological complaint . Has facial eye problem neurological complaint . Taking concomitant medication n't stable dos least 1 month prior study enrollment . Unable provide inform consent follow study direction . Has significant medical neurological condition preclude complete video protocol questionnaire . Has significant physical condition would confound diagnosis evaluation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>